These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 4047115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
    Nakagawara A, Ikeda K, Yokoyama T, Tsuda T, Higashi K.
    Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
    [Abstract] [Full Text] [Related]

  • 3. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J, De Vathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J.
    Cancer Res; 1991 Jan 01; 51(1):33-6. PubMed ID: 1988094
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
    Tsuda H, Shimosato Y, Upton MP, Yokota J, Terada M, Ohira M, Sugimura T, Hirohashi S.
    Lab Invest; 1988 Sep 01; 59(3):321-7. PubMed ID: 3411933
    [Abstract] [Full Text] [Related]

  • 6. Clinical implications of oncogene activation in human neuroblastomas.
    Brodeur GM, Seeger RC, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D.
    Cancer; 1986 Jul 15; 58(2 Suppl):541-5. PubMed ID: 3719548
    [Abstract] [Full Text] [Related]

  • 7. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 8. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
    Cohn SL, Rademaker AW, Salwen HR, Franklin WA, Gonzales-Crussi F, Rosen ST, Bauer KD.
    Am J Pathol; 1990 May 25; 136(5):1043-52. PubMed ID: 2349963
    [Abstract] [Full Text] [Related]

  • 9. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y, Kuwano M.
    Cancer Res; 1990 May 15; 50(10):3043-7. PubMed ID: 2185879
    [Abstract] [Full Text] [Related]

  • 10. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 11. myc gene amplification and expression in primary human neuroblastoma.
    Slavc I, Ellenbogen R, Jung WH, Vawter GF, Kretschmar C, Grier H, Korf BR.
    Cancer Res; 1990 Mar 01; 50(5):1459-63. PubMed ID: 2302711
    [Abstract] [Full Text] [Related]

  • 12. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G.
    Am J Pathol; 1993 Dec 01; 143(6):1543-50. PubMed ID: 8256847
    [Abstract] [Full Text] [Related]

  • 13. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 14. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct 01; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 15. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.
    Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K.
    Cancer; 1987 Aug 15; 60(4):820-6. PubMed ID: 3594401
    [Abstract] [Full Text] [Related]

  • 16. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R, Ambros PF, Urban C, Ambros IM, Fink FM, Zoubek A, Grienberger H, Schmitt K, Kerbl R, Horcher E, Amann G, Höfler G, Heinzl H, Gadner H, Mutz I.
    Klin Padiatr; 1996 Aug 15; 208(4):210-20. PubMed ID: 8926686
    [Abstract] [Full Text] [Related]

  • 17. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC.
    J Natl Cancer Inst; 1995 Oct 04; 87(19):1470-6. PubMed ID: 7674334
    [Abstract] [Full Text] [Related]

  • 18. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B.
    Med Pediatr Oncol; 2001 Jan 04; 36(1):11-3. PubMed ID: 11464859
    [Abstract] [Full Text] [Related]

  • 19. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.
    N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999
    [Abstract] [Full Text] [Related]

  • 20. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients.
    Brodeur GM, Hayes FA, Green AA, Casper JT, Wasson J, Wallach S, Seeger RC.
    Cancer Res; 1987 Aug 15; 47(16):4248-53. PubMed ID: 2440561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.